Designed to help pharmacists efficiently provide the latest evidence-based asthma care
The eAMS-Pharm has been built to empower pharmacists to play a meaningful role in chronic disease management. Through efficient workflows and by leveraging computerized decision support algorithms, it allows for rapid point-of-care interventions that exceed criteria for billable clinical services.
After analyzing responses to a simple asthma questionnaire, the eAMS-Pharm determines your patient’s asthma control level according to guidelines, then leverages the latest guideline evidence to provide specific medication adjustment recommendations.
The eAMS-Pharm facilitates meaningful, personalized chronic disease interventions. Through the eAMS-Pharm, pharmacists engage in more informed conversations, build trust, and provide patients with a new level of support throughout their asthma care journey. By providing consistent, high-quality, evidence-based advice, pharmacists can dramatically improve patients’ asthma quality of life, building stronger relationships, trust, and loyalty among patients and prescribers alike.
The system leverages patient data to auto-populate a self-management asthma action plan for delivery to the patient. This is an evidence-based intervention that empowers patients to self-manage asthma flares, reducing symptoms and healthcare visits.
After a quick 2-3 minute decision support workflow, the eAMS-Pharm generates a formatted informational letter for the prescriber, along with a medication authorization request or pharmacist prescription. It also provides an automated summary for pharmacy documentation, including for billable services.
The eAMS was designed in collaboration with physicians, educators, patients, and pharmacists, resulting in a tool tailored for your specific workflows. In over 15 years of development, more than 20 peer-reviewed publications supporting the eAMS have been published, including research demonstrating significant improvements in quality of care in busy real-world settings.
